AbbVie
ABBV
ABBV
2,014 hedge funds and large institutions have $106B invested in AbbVie in 2018 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 658 increasing their positions, 1,005 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
16% less funds holding in top 10
Funds holding in top 10: 164 → 137 (-27)
25% less call options, than puts
Call options by funds: $857M | Put options by funds: $1.14B
35% less repeat investments, than reductions
Existing positions increased: 658 | Existing positions reduced: 1,005
Holders
2,014
Holding in Top 10
137
Calls
$857M
Puts
$1.14B
Top Buyers
| 1 | +$581M | |
| 2 | +$569M | |
| 3 | +$550M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$331M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$330M |
Top Sellers
| 1 | -$500M | |
| 2 | -$489M | |
| 3 | -$434M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$320M |
| 5 |
State Street
Boston,
Massachusetts
|
-$302M |